Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib
Abstract
Psoriasiform eruptions have been described in patients treated with dupilumab. This case report describes an adolescent with severe atopic dermatitis who developed a widespread psoriasiform dermatitis 8 months after starting dupilumab. His therapy was switched to abrocitinib resulting in near-complete resolution of the psoriatic lesions with good atopic dermatitis control. This case adds to the limited pediatric literature on dupilumab-induced psoriasis and highlights abrocitinib as an effective therapeutic alternative capable of addressing both conditions concurrently.
Fields of Study & Subjects
Dermatology and Skin Diseases
Psoriasis: Treatment and Pathogenesis
Spondyloarthritis Studies and Treatments
Publication details
- Journal / source
- Pediatric Dermatology
- Publisher
- Wiley
- Volume
- 43
- Issue
- 5
- Pages
- 1241-1243
- Publication date
- 18 May 2026
- Language
- EN